123 results on '"Yeung, Jensen"'
Search Results
2. The efficacy and safety of switching between interleukin inhibitors in psoriasis therapy: A systematic review
3. Clinical manifestations and treatment outcomes in epidermolysis bullosa pruriginosa: A systematic review
4. Epigenetic and biological age acceleration in children with atopic dermatitis
5. Age affects drug survival rates of interleukin (IL)‐17 and IL‐23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi‐country, cohort study
6. Response to Biologic Therapy in Skin of Colour Participants With Moderate-to-Severe Psoriasis and Atopic Dermatitis: A Systematic Review
7. Use of sulfasalazine for psoriasis: An evidence-based review
8. Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients
9. Comorbidities and Risk Factors Associated With Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis
10. Onset of Vitiligo Within Patients Receiving Immune Checkpoint Inhibitors: An Evidence-Based Review
11. Cutaneous Eruptions Associated With Androgen Receptor Inhibitors for Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials
12. Hospitalization and Mortality in Patients With Darier Disease Complicated by Kaposi Varicelliform Eruption: A Systematic Review
13. Use of biologic treatment in psoriasis patients with HIV: A systematic review
14. Risk of infections among patients with psoriasis on Janus kinase inhibitor treatment: A systematic review and meta-analysis
15. Real-world effectiveness and safety of risankizumab in adult patients with plaque psoriasis: A 1-year international multicenter retrospective cohort study.
16. Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 16-week multicenter retrospective study.
17. Characteristics and management of sclerosing skin diseases during immune checkpoint inhibitor therapy: An evidence-based review.
18. Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review
19. Distinct Signatures of Mitotic Age Acceleration in Cutaneous Melanoma and Acquired Melanocytic Nevi
20. Onset of psoriasis with immune checkpoint inhibitor therapy: A systematic review.
21. Skin photoageing following sun exposure is associated with decreased epigenetic and biologic age, and correlates with basal cell carcinoma phenotype.
22. Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 16-week multicenter retrospective review
23. Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective study
24. The Rate of Infections With Janus Kinase Inhibitor Treatment for Atopic Dermatitis: A Systematic Review and Meta-Analysis.
25. 647 - Upadacitinib dose alterations in adolescent and adult patients with atopic dermatitis: a real-world multicenter retrospective review.
26. 645 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of long-term (week 52) data from a real-world multicenter retrospective review.
27. 644 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an interim analysis of week 20-32 data from a real-world multicenter retrospective review.
28. 643 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of short-term (week 8-20) data from a real-world multicenter retrospective review.
29. Machine Learning Applications in Psoriasis Treatment: A Systematic Review.
30. Use of Biologics for Cutaneous Sarcoidosis: A Systematic Review.
31. 54537 The Risk of Infections with Janus Kinase Inhibitor Treatment for Atopic Dermatitis: A Systematic Review and Meta-Analysis.
32. 53838 Real-world drug survival of risankizumab at a tertiary care psoriasis clinic in Toronto, Canada.
33. 54203 VISIBLE: Clearance and Symptom Improvement With Guselkumab at Week 16 in Skin of Color Participants With Moderate-to-Severe Plaque Psoriasis.
34. 53429 Use of Systemic Janus Kinase Inhibitors for Vitiligo: An Evidence-Based Review.
35. 54494 A systematic review and meta-analysis exploring the risk of infections with janus kinase inhibitor treatment for plaque psoriasis.
36. Development of Vitiligo in Patients Treated With BRAF/MEK Inhibitors: A Systematic Review.
37. Use of Dupilumab for Adult-Onset Atopic Dermatitis: A Real-World Retrospective Study.
38. Use of Janus Kinase Inhibitor Treatment for Palmoplantar Pustulosis: An Evidence-Based Review.
39. Elderly Onset Generalized Pustular Psoriasis: A Systematic Review.
40. Considerations for defining and diagnosing generalized pustular psoriasis.
41. Cutaneous Granulomatous Reactions in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review.
42. Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort Study.
43. Unraveling the Connection: A Systematic Review of HPV in Individuals With Psoriasis.
44. Seasonal Fluctuations in Atopic Dermatitis: A Global Perspective Using Google Trends Data.
45. Association of Proton Pump Inhibitors on Psoriasis Treatment and Development: A Systematic Review.
46. Janus Kinase Inhibitor Therapy for Cicatricial Alopecias: An Evidence-Based Review.
47. Treatment Outcomes in Erythema Annulare Centrifugum: A Systematic Review.
48. Gastrointestinal adverse events associated with use of biologic therapies available for psoriasis: a systematic review of pharmacovigilance studies.
49. Systemic Janus Kinase Inhibitor Treatment for Vitiligo: An Evidence-Based Review.
50. Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Short-Term (Week 8-20) Data from a Real-World Multicenter Retrospective Review.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.